Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYVERSA THERAPEUTICS INC

0.7450
+0.04406.28%
Post-market: 0.6943-0.0507-6.81%17:27 EDT
Volume:37.49K
Turnover:27.64K
Market Cap:1.87M
PE:-0.02
High:0.7450
Open:0.7019
Low:0.7019
Close:0.7010
Loading ...

ZyVersa Therapeutics Highlights Data Published in the Journal of the American Heart Association Demonstrating Inflammasome Inhibition Attenuates Obesity-Associated Cardiomyopathy in Animal Model Study

GlobeNewswire
·
18 Mar

ZyVersa Therapeutics prices 2.1M shares at 95c in private placement

TIPRANKS
·
06 Mar

Zyversa Therapeutics, Inc. Announces Pricing of $2.0 Million Private Placement Priced at the Market

THOMSON REUTERS
·
06 Mar

ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition

TIPRANKS
·
05 Mar

BRIEF-Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing

Reuters
·
21 Dec 2024

OTC Markets Hosts Virtual Investor Presentation with Stephen Glover, CEO of ZyVersa Therapeutics, Inc., with Brad Sorensen, Senior Analyst at Zacks SCR

Zacks Small Cap Research
·
21 Nov 2024

ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100

TIPRANKS
·
20 Nov 2024

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire
·
15 Nov 2024

ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate

Benzinga
·
14 Nov 2024

Zyversa Therapeutics - Qtrly Loss per Share $2.43

THOMSON REUTERS
·
14 Nov 2024

Life Sciences Investor Forum Agenda Announced for November 14th

GlobeNewswire
·
12 Nov 2024

S&P 500 Gains 1%; Vimeo Shares Spike Higher

Benzinga
·
06 Nov 2024

ZyVersa Says Data Show Inflammasome Inhibition May Slow Obesity-Linked Diabetes; Shares Jump

MT Newswires Live
·
05 Nov 2024

Top Premarket Gainers

MT Newswires Live
·
05 Nov 2024

Zyversa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression From Obesity to Insulin Resistance and Type 2 Diabetes

THOMSON REUTERS
·
05 Nov 2024

ZyVersa highlights review article on inflammasome-induced inflammation

TIPRANKS
·
29 Oct 2024